BioCentury | Apr 15, 2013
Company News

Somatogen blood products/substitutes news

...Hoogheem. SMTG had been spending close to $1.5 million per month prior to the restructuring. Somatogen Inc....
BioCentury | Jul 26, 2012
Targets & Mechanisms

Crafty air carrier

...from now-defunct Northfield Laboratories Inc. , HemAssist from Baxter International Inc. and Optro rHb1.1 from Somatogen Inc....
BioCentury | Apr 3, 2006
Company News

Corgenix Medical Corp. board of directors update

...Corp. (CONX), Westminster, Colo. Business: Diagnostic, Cardiovascular Appointed: Charles Scoggin, former president and CEO of Somatogen Inc....
BioCentury | Sep 7, 1999
Strategy

Back to School 1999: Structure 2000

...$199.00 $175.30 $445.20 $360.10 $319.40 SkyePharma (LSE:SKP; SKYE) IPO 1/96 ($152.0M) $420.40 $529.00 $778.60 $468.80 Somatogen...
...$199.00 $175.30 $445.20 $360.10 $319.40 SkyePharma (LSE:SKP; SKYE) IPO 1/96 ($152.0M) $420.40 $529.00 $778.60 $468.80 Somatogen...
BioCentury | Sep 21, 1998
Company News

Baxter Healthcare Corp. blood products/substitutes news

...engineered hemoglobin molecules being developed at its Baxter Hemoglobin Therapeutics Inc. subsidiary (Boulder, Colo.), formerly Somatogen Inc....
BioCentury | Sep 14, 1998
Company News

Quidel management update

...Business: Diagnostics/Imaging Hired: Timothy Hoogheem as acting CFO, formerly VP of finance and administration at Somatogen Inc....
BioCentury | Aug 17, 1998
Regulation

Size matters in blood substitute trials

...II trials of its Optro rHb1.1 recombinant hemoglobin product, which Baxter inherited when it acquired Somatogen Inc....
BioCentury | Jul 6, 1998
Company News

Baxter Hemoglobin Therapeutics Inc. other research news

...The company, formerly Somatogen Inc. , and colleagues published in Nature Biotechnology the synthesis of recombinant hemoglobin...
BioCentury | Jun 29, 1998
Strategy

Get a product - get acquired

...With the exception of Baxter International Inc. 's purchase of Somatogen Inc. in February, pharmaceutical company acquisitions...
BioCentury | Jun 15, 1998
Company News

Quidel management update

...and CEO, while remaining vice chairman of the board, formerly chairman, president and CEO of Somatogen Inc. WIR...
Items per page:
1 - 10 of 65
BioCentury | Apr 15, 2013
Company News

Somatogen blood products/substitutes news

...Hoogheem. SMTG had been spending close to $1.5 million per month prior to the restructuring. Somatogen Inc....
BioCentury | Jul 26, 2012
Targets & Mechanisms

Crafty air carrier

...from now-defunct Northfield Laboratories Inc. , HemAssist from Baxter International Inc. and Optro rHb1.1 from Somatogen Inc....
BioCentury | Apr 3, 2006
Company News

Corgenix Medical Corp. board of directors update

...Corp. (CONX), Westminster, Colo. Business: Diagnostic, Cardiovascular Appointed: Charles Scoggin, former president and CEO of Somatogen Inc....
BioCentury | Sep 7, 1999
Strategy

Back to School 1999: Structure 2000

...$199.00 $175.30 $445.20 $360.10 $319.40 SkyePharma (LSE:SKP; SKYE) IPO 1/96 ($152.0M) $420.40 $529.00 $778.60 $468.80 Somatogen...
...$199.00 $175.30 $445.20 $360.10 $319.40 SkyePharma (LSE:SKP; SKYE) IPO 1/96 ($152.0M) $420.40 $529.00 $778.60 $468.80 Somatogen...
BioCentury | Sep 21, 1998
Company News

Baxter Healthcare Corp. blood products/substitutes news

...engineered hemoglobin molecules being developed at its Baxter Hemoglobin Therapeutics Inc. subsidiary (Boulder, Colo.), formerly Somatogen Inc....
BioCentury | Sep 14, 1998
Company News

Quidel management update

...Business: Diagnostics/Imaging Hired: Timothy Hoogheem as acting CFO, formerly VP of finance and administration at Somatogen Inc....
BioCentury | Aug 17, 1998
Regulation

Size matters in blood substitute trials

...II trials of its Optro rHb1.1 recombinant hemoglobin product, which Baxter inherited when it acquired Somatogen Inc....
BioCentury | Jul 6, 1998
Company News

Baxter Hemoglobin Therapeutics Inc. other research news

...The company, formerly Somatogen Inc. , and colleagues published in Nature Biotechnology the synthesis of recombinant hemoglobin...
BioCentury | Jun 29, 1998
Strategy

Get a product - get acquired

...With the exception of Baxter International Inc. 's purchase of Somatogen Inc. in February, pharmaceutical company acquisitions...
BioCentury | Jun 15, 1998
Company News

Quidel management update

...and CEO, while remaining vice chairman of the board, formerly chairman, president and CEO of Somatogen Inc. WIR...
Items per page:
1 - 10 of 65